EYEN Eyenovia
- 0.746
- +0.009+1.18%
Eyenovia News
Eyenovia | 424B5: Prospectus
Eyenovia | 8-K: Current report
Eyenovia | 8-K: Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol
Eyenovia | 10-Q: Quarterly report
Eyenovia | ARS: Annual Report to Security Holders
Eyenovia | DEF 14A: Definitive information statements
Eyenovia | 10-K/A: Annual report (Amendment)
Eyenovia | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Eyenovia | 424B5: Prospectus
Eyenovia | 8-K: Current report
Eyenovia | 8-K: Current report
Eyenovia | 8-K: Current report
Eyenovia | 4: Statement of changes in beneficial ownership of securities-10% Owner Grant Stuart M.
Eyenovia | 4: Statement of changes in beneficial ownership of securities-10% Owner Grant Stuart M.
Eyenovia | 8-K: Current report
Eyenovia | 10-K: Annual report
Eyenovia | 4: Statement of changes in beneficial ownership of securities-10% Owner Grant Stuart M.
Eyenovia | 4: Statement of changes in beneficial ownership of securities-Officer Kern Bren
Eyenovia | 4: Statement of changes in beneficial ownership of securities-Officer GANDOLFO JOHN P
Eyenovia | 4: Statement of changes in beneficial ownership of securities-Officer Rowe Michael M
Analysis
Price Target
No Data
